CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 98 enrolled
Drug / intervention
Celecoxib +1 moredrug
Likely dose
Celecoxib 400 mg orally prior to surgeryAI-extracted
Key inclusion· 1
  • ✓Undergoing hip arthroscopy procedure at Northwestern Memorial Hospital
Key exclusion· 2
  • ✕Pregnant women
  • ✕Age under 18 years

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02779166
NCT02779166N/ACompleted
CompareCT.gov

Evaluation of Perioperative Celecoxib for Hip Arthroscopy

Northwestern University·interventional·Posted May 20, 2016·Updated Sep 23, 2019

In Brief

A clinical study evaluating Celecoxib and placebo for Hip Labral Tears. Completed, enrolled 98 participants.

Detailed Summary

Celecoxib is commonly used for perioperative pain control for certain orthopaedic procedures. It has been shown to be successful in assisting in pain control for knee arthroscopy. It has not previously been studied in hip arthroscopy. This is a double blinded randomized controlled trial to determine the efficacy of celecoxib in perioperative pain control for hip arthroscopy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHip Labral Tears
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 20, 2016
Enrollment StartAug 1, 2012
Primary CompletionJan 1, 2016
Study CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 10.1 years ago

Interventions

Celecoxibdrug

Received 400mg celecoxib prior to surgery

placebodrug